Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Gajanand Mittal"'
Autor:
Gajanand Mittal, Vasundhra Bhandari, Rajni Gaind, Vandana Rani, Shimpi Chopra, Reetika Dawar, Raman Sardana, P. K. Verma
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Coagulase-negative Staphylococci (CoNS) have emerged as a major causative agent of blood-stream infections (BSI). Linezolid (LZD) is currently used for treating glycopeptide and methicillin-resistant staphylococci. It is important
Externí odkaz:
https://doaj.org/article/40f2bd6b74844b1aa41acbd25e5b1553
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 7, Iss 1, Pp 1-11 (2018)
Abstract Background Hospital acquired infections (HAI) are principal threats to the patients of intensive care units. An increase in the antimicrobial resistance (AMR) observed in gram negative bacteria is a great challenge to deal with. HAI and AMR
Externí odkaz:
https://doaj.org/article/f377c771f7eb4558af36fecafa2fe11d
Autor:
Vivek Verma, D. Nagarjuna, Gajanand Mittal, Parveen Kumar, Rakesh Singh Dhanda, Rajni Gaind, Manisha Yadav
Publikováno v:
Data in Brief, Vol 7, Iss , Pp 794-797 (2016)
Bacterial virulence factors (VFs) influence the site and severity of urinary tract infections (UTI) and further leading to sepsis infection. Phenotypic characterisation of VFs specific to sepsis Escherichia coli strains has not been characterized in
Externí odkaz:
https://doaj.org/article/633b6f6bd4724810a753e27b7870079d
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 11, Iss 10, Pp DD01-DD03 (2017)
Medicopsis romeroi (M. romeroi) (syn. Pyrenochaeta romeroi) is a rare melanized fungus causing subcutaneous/localized invasive phaeohyphomycosis in immunocompromised patients. We present a rare case of subcutaneous phaeohypho-mycotic cyst caused by M
Externí odkaz:
https://doaj.org/article/75488765a0ea48a5a0037b4f5c02d9b1
Autor:
Reetika Dawar, Vandana Rani, Shimpi Chopra, Raman Sardana, Rajni Gaind, Gajanand Mittal, Vasundhra Bhandari, Pardeep Kumar Verma
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-8 (2019)
BMC Infectious Diseases
BMC Infectious Diseases
Background Coagulase-negative Staphylococci (CoNS) have emerged as a major causative agent of blood-stream infections (BSI). Linezolid (LZD) is currently used for treating glycopeptide and methicillin-resistant staphylococci. It is important to under
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 7, Iss 1, Pp 1-11 (2018)
Antimicrobial Resistance and Infection Control
Antimicrobial Resistance and Infection Control
Background Hospital acquired infections (HAI) are principal threats to the patients of intensive care units. An increase in the antimicrobial resistance (AMR) observed in gram negative bacteria is a great challenge to deal with. HAI and AMR lead to p
Autor:
Manisha Yadav, D. Nagarjuna, Gajanand Mittal, Vivek Verma, Rakesh Singh Dhanda, Rajni Gaind, Parveen Kumar
Publikováno v:
Data in Brief, Vol 7, Iss, Pp 794-797 (2016)
Bacterial virulence factors (VFs) influence the site and severity of urinary tract infections (UTI) and further leading to sepsis infection. Phenotypic characterisation of VFs specific to sepsis Escherichia coli strains has not been characterized in
Autor:
Gajanand Mittal, Prashant Verma, Rajni Gaind, Gaurav Kaushik, Deepak Kumar, Monorama Deb, Kunj Bihari Gupta
Publikováno v:
BMC Microbiology
Background Resistance amongst the commensal flora is a serious threat because a very highly populated ecosystem like the gut, may at a later stage, be a source of extra intestinal infections, resistant strains may spread to other host or transfer gen
Autor:
Gajanand Mittal, Gaind, Rajni, Kumar, Deepak, Gaurav Kaushik, Kunj Gupta, P. Verma, Monorama Deb
Proforma used for collection of data. (DOC 32Â kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::928bc7e2ce2f82f6a4b637e4306102ed
Publikováno v:
New Microbes and New Infections, Vol 7, Iss C, Pp 57-66 (2015)
New Microbes and New Infections
New Microbes and New Infections
Nosocomial infections are acquired during hospital treatment or in a hospital environment. One such infecting agent, Escherichia coli, harbours many virulence genes that enable it to become pathogenic, causing damage to the host. The mechanism of the